Gilead Sciences' Research Scholars Program supports early-career researchers pursuing innovative studies in virology, oncology, and liver disease to advance scientific understanding and patient care.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2027 (Full application deadline, projected)
Funding Amounts: Typically $180,000 USD over 2 years (paid in annual installments); award amounts may vary globally.
Summary: Supports independent, innovative research by emerging investigators in virology, oncology, and liver disease.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.
The Research Scholars Program by Gilead Sciences is designed to foster innovative, independent research from emerging investigators worldwide, with a focus on advancing scientific understanding and addressing unmet needs in virology (including HIV and viral hepatitis), oncology (solid tumors), and liver disease. Since 2008, the program has aimed to support new perspectives, diverse voices, and research projects that can drive breakthroughs in areas of significant medical need. The program also emphasizes reducing barriers for underrepresented groups in research and supports projects that address health inequities.